| Description | ABBV-221 is an intravenously administered drug that modulates the activity of epidermal growth factor receptor (EGFR) and has potential antitumor activity. |
| Synonyms | ABBV 221 |
| molecular weight | N/A |
| CAS | 1165741-01-4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |